Background: Basal cell carcinoma (BCC), the most prevalent form of cancer worldwide, is a malignant skin neoplasm. It is locally invasive, with an exceptional incidence of reported metastasis. It can also be part of the Gorlin-Goltz syndrome, an autosomal dominant genetic disorder with high penetrance and variable expressivity, which is principally characterized by cutaneous BCC, odontogenic keratocysts, palmar and/or plantar pits, and falx cerebri calcification. Observation: We report the exceptional clinical observation of a 54-year-old man presenting bone metastasis from BCC in Gorlin-Goltz syndrome. Conclusion: Less than 300 cases of metastatic BCC have been reported in the literature. The present case is the second associated with Gorlin-Goltz syndrome.

Keywords:
Basal cell carcinoma, Nevoid basal cell carcinoma syndrome, Gorlin-Goltz syndrome, Metastasis, Radiotherapy
1.
Robinson JK, Dahiya M: Basal cell carcinoma with pulmonary and lymph node metastasis causing death. Arch Dermatol 2003;139:643–648.
2.
Berlin JM, Warner MR, Bailin PL: Metastatic basal cell carcinoma presenting as unilateral axillary lymphadenopathy: report of a case and review of the literature. Dermatol Surg 2002;28:1082–1084.
3.
Gorlin RJ, Goltz RW: Multiple nevoid basal-cell epithelioma, jaw cysts and bifid rib: a syndrome. N Engl J Med 1960;262:908–912.
4.
Hahn H, Wicking C, Zaphiropoulous PG, et al: Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 1996;85:841–851.
5.
Manfredi M, Vescovi P, Bonanini M, Porter S: Nevoid basal cell carcinoma syndrome: a review of the literature. Int J Oral Maxillofac Surg 2004;33:117–124.
6.
Lam CW, Leung CY, Lee KC, et al: Novel mutations in the PATCHED gene in basal cell nevus syndrome. Mol Genet Metab 2002;76:57–61.
7.
Jarish W: Zur Lehre von den Hautgeschwulsten. Arch Dermatol Sypholol (Berl) 1894;28:162–222.
8.
White JC: Multiple benign cystic epitheliomas. J Cutan Genitourin Dis 1894;12:477–484.
9.
Ortega Garcia de Amezaga A, Garcia Arregui O, Zepeda Nuno S, Acha Sagredo A, Aguirre Urizar JM: Gorlin-Goltz syndrome: clinicopathologic aspects. Med Oral Patol Oral Cir Bucal 2008;13:E338–E343.
10.
Winkler PA, Guyuron B: Multiple metastases from basal cell naevus syndrome. Br J Plast Surg 1987;40:528–531.
11.
Beadles CF: Rodent Ulcer Trans Pathol Soc (Lond) 1894;45:176–181.
12.
Malone JP, Fedok FG, Belchis DA, Maloney ME: Basal cell carcinoma metastatic to the parotid: report of a new case and review of the literature. Ear Nose Throat J 2000;79:511–515, 518–519.
13.
Ting PT, Kasper R, Arlette JP: Metastatic basal cell carcinoma: report of two cases and literature review. J Cutan Med Surg 2005;9:10–15.
14.
Caccialanza M, Percivalle S, Piccinno R: Possibility of treating basal cell carcinomas of nevoid basal cell carcinoma syndrome with superficial x-ray therapy. Dermatol 2004;208:60–63.
15.
Lo Muzio L: Nevoid basal cell carcinoma syndrome (Gorlin syndrome). Orphanet J Rare Dis 2008;3:32.
16.
Wallin JL, Tanna N, Misra S, Puri PK, Sadeghi N: Sinonasal carcinoma after irradiation for medulloblastoma in nevoid basal cell carcinoma syndrome. Am J Otolaryngol 2007;28:360–362.
© 2009 S. Karger AG, Basel
2009
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.